Biofil Chemicals & Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 9.26 | 8.59 | 14.22 |
| Operating Expense | 6.43 | 8.24 | 13.89 |
| Net Profit | 2.41 | 0.20 | 0.16 |
| Net Profit Margin | 26.03 | 2.33 | 1.13 |
| Earning Per Share | 1.48 | 0.12 | 0.10 |
| EBIDTA | 2.84 | 0.38 | 0.33 |
| Effective Tax Rate | 12.32 | 26.47 | 18.18 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 9.26 |
| Operating Expense | 6.43 |
| Net Profit | 2.41 |
| Net Profit Margin | 26.03 |
| Earning Per Share | 1.48 |
| EBIDTA | 2.84 |
| Effective Tax Rate | 12.32 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 33.40 | 40.04 | 30.04 |
| Operating Expenses Annual | 32.55 | 39.22 | 28.87 |
| Operating Profit Annual | 1.15 | 1.31 | 1.26 |
| Interest Annual | 0.04 | 0.04 | 0.04 |
| Depreciation | 0.38 | 0.40 | 0.43 |
| Net Profit Annual | 0.56 | 0.71 | 0.56 |
| Tax Annual | 0.18 | 0.16 | 0.23 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 33.40 |
| Operating Expenses Annual | 32.55 |
| Operating Profit Annual | 1.15 |
| Interest Annual | 0.04 |
| Depreciation | 0.38 |
| Net Profit Annual | 0.56 |
| Tax Annual | 0.18 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 2.28 | 0.04 | 0.14 |
| Cash Flow from Operations | -1.92 | 2.39 | -0.11 |
| Cash Flow from Investing | -0.10 | -0.02 | -0.01 |
| Cash Flow from Financing | TBA | -0.12 | 0.02 |
| Cash Flow at the End | 0.26 | 2.28 | 0.04 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 2.28 |
| Cash Flow from Operations | -1.92 |
| Cash Flow from Investing | -0.10 |
| Cash Flow from Financing | TBA |
| Cash Flow at the End | 0.26 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 3.47 | 3.25 | 4.19 |
| PBIT Margin (%) | 2.34 | 2.25 | 2.76 |
| PBT Margin (%) | -56.04 | -54.57 | -66.31 |
| Net PROFIT Margin (%) | 1.68 | 1.77 | 1.86 |
| Return On Networth / Equity (%) | 1.12 | 1.42 | 1.12 |
| Return On Networth /Employed (%) | 1.54 | 1.80 | 1.65 |
| Return On Assets (%) | 2.95 | 3.90 | 3.19 |
| Total Debt / Equity (X) | 0.02 | 0.03 | 0.03 |
| Asset Turnover Ratio (%) | 1.76 | 2.20 | 1.71 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 3.47 |
| PBIT Margin (%) | 2.34 |
| PBT Margin (%) | -56.04 |
| Net PROFIT Margin (%) | 1.68 |
| Return On Networth / Equity (%) | 1.12 |
| Return On Networth /Employed (%) | 1.54 |
| Return On Assets (%) | 2.95 |
| Total Debt / Equity (X) | 0.02 |
| Asset Turnover Ratio (%) | 1.76 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 8.34 | 8.62 | 9.00 |
| Total Current Assets Annual | 42.55 | 38.41 | 22.35 |
| Non Current Assets Annual | 8.41 | 8.68 | 9.05 |
| Total Shareholders Funds Annual | 18.78 | 18.20 | 17.30 |
| Total Assets Annual | 50.96 | 47.08 | 31.41 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 8.34 |
| Total Current Assets Annual | 42.55 |
| Non Current Assets Annual | 8.41 |
| Total Shareholders Funds Annual | 18.78 |
| Total Assets Annual | 50.96 |
No Data Availabe
